Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigations

Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-l-Tyrosine PET in Comparison to MRI

Norbert Galldiks, Karl-Josef Langen, Richard Holy, Michael Pinkawa, Gabriele Stoffels, Kay W. Nolte, Hans J. Kaiser, Christan P. Filss, Gereon R. Fink, Heinz H. Coenen, Michael J. Eble and Marc D. Piroth
Journal of Nuclear Medicine July 2012, 53 (7) 1048-1057; DOI: https://doi.org/10.2967/jnumed.111.098590
Norbert Galldiks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl-Josef Langen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Holy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Pinkawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriele Stoffels
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kay W. Nolte
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans J. Kaiser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christan P. Filss
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gereon R. Fink
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heinz H. Coenen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Eble
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc D. Piroth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 53 (7)
Journal of Nuclear Medicine
Vol. 53, Issue 7
July 1, 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-l-Tyrosine PET in Comparison to MRI
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-l-Tyrosine PET in Comparison to MRI
Norbert Galldiks, Karl-Josef Langen, Richard Holy, Michael Pinkawa, Gabriele Stoffels, Kay W. Nolte, Hans J. Kaiser, Christan P. Filss, Gereon R. Fink, Heinz H. Coenen, Michael J. Eble, Marc D. Piroth
Journal of Nuclear Medicine Jul 2012, 53 (7) 1048-1057; DOI: 10.2967/jnumed.111.098590

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-l-Tyrosine PET in Comparison to MRI
Norbert Galldiks, Karl-Josef Langen, Richard Holy, Michael Pinkawa, Gabriele Stoffels, Kay W. Nolte, Hans J. Kaiser, Christan P. Filss, Gereon R. Fink, Heinz H. Coenen, Michael J. Eble, Marc D. Piroth
Journal of Nuclear Medicine Jul 2012, 53 (7) 1048-1057; DOI: 10.2967/jnumed.111.098590
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE STATEMENT
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • Erratum
  • PubMed
  • Google Scholar

Cited By...

  • Amino Acid PET in Neurooncology
  • Amino Acid PET in Neurooncology
  • Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
  • Early Treatment Response Assessment Using 18F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy
  • Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences
  • Influence of Bevacizumab on Blood-Brain Barrier Permeability and O-(2-18F-Fluoroethyl)-L-Tyrosine Uptake in Rat Gliomas
  • Combined PET Imaging of the Inflammatory Tumor Microenvironment Identifies Margins of Unique Radiotracer Uptake
  • Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM
  • Clinical Impact of Amino Acid PET in Gliomas
  • Comparison of 18F-FET PET and Perfusion-Weighted MR Imaging: A PET/MR Imaging Hybrid Study in Patients with Brain Tumors
  • Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma
  • Google Scholar

More in this TOC Section

  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
  • Prognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire